CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFECTIVENESS OF THOKKANAM [ PIDITHAL AND AZHUTTHAL MURAI ] USING NALVELAI VATHA ENNAI (EXTERNAL) IN THE MANAGEMENT OF THANDAGA VATHAM [ LUMBAR SPONDYLOSIS ].

AN OPEN LABELLED NON RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFECTIVENESS OF THOKKANAM [ PIDITHAL AND AZHUTTHAL MURAI ] USING NALVELAI VATHA ENNAI (EXTERNAL) IN THE MANAGEMENT OF THANDAGA VATHAM [ LUMBAR SPONDYLOSIS ]. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105658

Enrollment

Registered

2026-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: THOKKANAM [ PIDITHAL AND AZHUTTHAL MURAI ] USING NALVELAI VATHA ENNAI: THOKKANAM [ PIDITHAL AND AZHUTTHAL MURAI ] USING NALVELAI VATHA ENNAI FOR 7 DAYS FOR 15 TO 20 MINS Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: Participants having symptoms of pain in the lumbar region. Participants having radiating pain to gluteal and lower limbs. Participants having stiffness/ muscle spasm present in lumbar region. Participants having pain during forward bending of spine. Participants with or without numbness and burning sensation in lower limbs. Participants with positive signs for the specific lumbar examinations. Participants who are willing to attend OPD and admission and stay in IPD. Positive radiological findings (X ray/CT/MRI) for lumbar spondylosis. Participants with mild to moderate grade of symptoms.

Exclusion criteria

Exclusion criteria: Participants with recent H/O trauma, fracture, dislocation and surgery. Participants with H/O cardiac diseases. Participants with severe disc bulge, disc protrusion, disc herniation and disc sequestration. Autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus, psoriasis, mixed connective tissue disorders. Ankylosing spondylitis, Tuberculosis of lumbar spine, cauda equina syndrome, osteomyelitis etc. Spina bifida and any other deformity of vertebral spine. Renal calculi. Pregnancy and lactating women. Any other serious illness like any other skin disease and skin infection Participants who need internal medicines.

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effectiveness of THOKKANAM using NALVELAI VATHA ENNAI (EXTERNAL) in the management of THANDAGA VATHAM (LUMBAR SPONDYLOSIS) and Reduction of pain, muscle spasm, numbness, burning sensation and increase in range of motion in lumbar spine is assessed by clinical assessments.Timepoint: 7 DAYS	—

Secondary

Measure	Time frame
To assess the safety profile of Thokkanam therapy with NALVELAI VATHA ENNAI To document the basic siddha diagnostic tool Naadi and Neikuri of the participants before and after treatment.Timepoint: 7 DAYS	—

Countries

India

Contacts

Public ContactDR SUJATHA S MDs

GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, PALAYAMKOTTAI

sujatharajasekar66@gmail.com9442331462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026